32 results match your criteria: "Formulation Research Institute[Affiliation]"

In Vivo Animal Spices and Experimental Technique to Evaluate Sustained Release Granules.

Biopharm Drug Dispos

January 2025

Bioavailability Research Project, Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan.

Establishment of a suitable animal model to evaluate sustained release (SR) formulations is very important because it reduces the development time of SR formulations. Beagle dogs are often used to evaluate prototype formulations since they can be directly administered powder, such as drug substance. However, the physiological condition of dogs is very different to that of humans.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the growing use of UAVs for applying plant protection products (PPPs) in paddy fields, focusing on challenges like canopy penetration, spray drift, and uneven application.
  • Researchers tested two adjuvants, Wonderful Rosin and Tiandun, at six concentrations to see how they affect spray properties and the effectiveness of insecticides against rice pests.
  • Results showed that using these adjuvants improved spray performance, reduced drift, and increased pest control efficacy, particularly at a concentration of 0.5%, offering insights for better UAV spraying practices in agriculture.
View Article and Find Full Text PDF

Genetic drugs have the potential to treat a variety of diseases. Recently, lipid nanoparticles (LNPs) have attracted much attention among drug delivery systems for genetic drugs. LNPs have been practically used in small interfering RNA (siRNA) drugs and mRNA vaccines.

View Article and Find Full Text PDF

The dissolution behaviors of base excipients from sustained-release formulations have been investigated using various methodologies. However, the dissolution of polymers has not been fully evaluated because differences between formulations are still verified only by the release of active pharmaceutical ingredients (APIs). In our previous study, we proposed a quick and simultaneous analysis of dissolved APIs and water-soluble polymers by ultra HPLC using charged aerosol and photodiode array detectors.

View Article and Find Full Text PDF

A quantitative evaluation method for determining the effect of tableting speed on the compression properties of pharmaceutical powders was investigated in this study. Cilostazol and ibuprofen were used as active pharmaceutical ingredients (APIs) and mixed with lactose monohydrate and microcrystalline cellulose. Viscoelasticity was examined to evaluate the raw material, and stress relaxation tests were conducted to determine the apparent viscosity and elasticity coefficients of the placebo and two APIs.

View Article and Find Full Text PDF

The objective of the study is to develop a quick and simultaneous analysis system for the dissolution of the active pharmaceutical ingredient (API) and the formulation excipient in samples from the dissolution test by UHPLC using the charged aerosol and PDA detectors. The combination of two columns for size-exclusion chromatography (SEC) and the equipment of the charged aerosol detector allowed the quick determination of various water-soluble polymers. Three model sustained-release tablets, each containing a different API of different water solubility (propranolol (soluble), ranitidine (very soluble), and cilostazol (practically insoluble)), were prepared from polyethylene oxide (PEO) matrix to verify the applicability and utility of the analysis system.

View Article and Find Full Text PDF

Spermine with Sodium Taurocholate Enhances Pulmonary Absorption of Macromolecules in Rats.

J Pharm Sci

October 2021

Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, kita-ku, Okayama 700-8530, Japan.

The improvement effect of the combined use of spermine (SPM), a polyamine, with sodium taurocholate (STC) on the pulmonary drug absorption was investigated utilizing poorly absorbable drugs with various molecular sizes in rats. The pulmonary absorption of rebamipide, a low molecular but poorly absorbable drug after oral administration, was significantly improved by the combined use of SPM with STC (SPM-STC formulation), while poly- L-lysine did not show a significant change in rebamipide absorption from the lungs. Furthermore, the safety of the SPM-STC formulation for the lungs was assessed in rats by the histopathological study and any local toxicity was not observed while poly-L-lysine, a typical chemical causing the toxicity for the epithelial cells, provided several histopathological changes.

View Article and Find Full Text PDF

Cilostazol (CLZ) is categorized as a biopharmaceutical classification system (BCS) class II drug. CLZ suspensions of jet-milled particles were orally administered to beagle dogs in fasted and fed states, for which food was given 0.5 h before the experiment.

View Article and Find Full Text PDF

Simultaneous Prediction of Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber System.

J Pharm Sci

January 2019

Bioavailability Research Project, Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., 224-18 Ebisuno Hiraishi Kawauchi-cho, Tokushima 771-0182, Japan; Quality Assurance Section, Quality Assurance Department, Headquarters for Product Safety and Quality Assurance, Otsuka Pharmaceutical Co. Ltd., Matsudani Itano-cho, Itano-gun, Tokushima 779-0195, Japan. Electronic address:

The purpose of this study was to investigate the possibility of simultaneous prediction of the intestinal absorption and metabolism in a mini-Ussing chamber equipped with rat intestinal tissues, based on the transport index (TI). TI value was defined as the sum of drug amounts, by mass balance method, transported to the basal-side component and drug amounts accumulated in the tissue, which are normalized by area under the curve of the drug in the apical compartment. Midazolam and nifedipine with high permeability were used as typical P450 substrates to examine the possibility of simultaneous prediction of intestinal absorption and metabolism.

View Article and Find Full Text PDF

Evaluation of intestinal metabolism and absorption using the Ussing chamber system equipped with intestinal tissue from rats and dogs.

Eur J Pharm Biopharm

January 2018

Bioavailability Research Project, Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., 224-18 Ebisuno Hiraishi Kawauchi-cho, Tokushima 771-0182, Japan.

The purpose of this study was to evaluate the intestinal metabolism and absorption in a mini-Ussing chamber equipped with animal intestinal tissues, based on the transport index (TI). TI value was defined as the sum of drug amounts transported to the basal-side component (X) and drug amounts accumulated in the tissue (T), which are normalized by AUC of a drug in the apical compartment, as an index for drug absorption. Midazolam was used as a test compound for the evaluation of intestinal metabolism and absorption.

View Article and Find Full Text PDF

We investigate the inhibitory effect of marketed drugs for treatment of inflammatory bowel disease (IBD) such as ulcerative colitis (UC) and Crohn's disease (CD) on the uptake transporters of peptide transporter 1 (PEPT1), which are up-regulated under the inflamed condition. The uptake transport of glycylsarcosine, a typical substrate for PEPT1, was reduced to 60% only by 5-aminosalicylate at the clinically relevant concentration among tested marketed drugs in PEPT1 transfected HEK293 cell lines. These findings suggest that the inhibition of PEPT1, which were up-regulated in inflamed or non-inflamed site on UC and CD patients, contribute to the clinical effect of commercially available drugs for IBD patients through the inhibition of uptake of antigenic proinflammatory oligopeptides such as formyl-methionine (Met)-leucine (Leu)-phenylalanine (Phe) via PEPT1.

View Article and Find Full Text PDF

Preparation of an Ultrafine Rebamipide Ophthalmic Suspension with High Transparency.

Biol Pharm Bull

February 2018

Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University.

A 2% commercially available, milky-white, rebamipide micro-particle suspension is used to treat dry eyes, and it causes short-term blurring of the patient's vision. In the current study, to improve the transparency of a rebamipide suspension, we attempted to obtain a clear rebamipide suspension by transforming the rebamipide particles to an ultrafine state. In the initial few efforts, various rebamipide suspensions were prepared using a neutralizing crystallization method with additives, but the suspensions retained their opaque quality.

View Article and Find Full Text PDF

Therapeutic peptides and protein are being used in several indications; however, their poor permeability still remains to be solved. This study focused on the pulmonary route of macromolecules. First, the effects of arachidonic acid (AA) as an absorption enhancer on drug serum concentration, after intratracheal administration, were investigated in rats.

View Article and Find Full Text PDF

Prediction of drug intestinal absorption in human using the Ussing chamber system: A comparison of intestinal tissues from animals and humans.

Eur J Pharm Sci

January 2017

Bioavailability Research Project, Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., 224-18 Ebisuno Hiraishi Kawauchi-cho, Tokushima 771-0182, Japan.

An adequate evaluation system for drug intestinal absorption is essential in the pharmaceutical industry. Previously, we established a novel prediction system of drug intestinal absorption in humans, using the mini-Ussing chamber equipped with human intestinal tissues. In this system, the TI value was defined as the sum of drug amounts transported to the basal-side component (X) and drug amounts accumulated in the tissue (T), which are normalized by AUC of a drug in the apical compartment, as an index for drug absorption.

View Article and Find Full Text PDF

Effect of proinflammatory cytokine IL-6 on efflux transport of rebamipide in Caco-2 cells.

Xenobiotica

September 2017

a Drug Delivery Research, Department of Pharmacy, Uppsala University, Uppsala , Sweden and.

Article Synopsis
  • The study examined how the pro-inflammatory cytokine IL-6 affects the transport of rebamipide, which is used for treating ulcers, in Caco-2 cells.
  • It was found that rebamipide moves more easily from the basal to apical side than the other way around, and its transport is blocked by certain inhibitors, but not by every type of inhibitor tested.
  • IL-6 increased transport rates for mannitol but did not affect the transport of rebamipide, suggesting compensatory mechanisms in drug transport that might keep rebamipide absorption stable in patients with inflammatory bowel disease (IBD).
View Article and Find Full Text PDF

The aim of this study was to investigate whether the pro-inflammatory cytokines improved the function of the cell monolayer model of the human follicle-associated epithelium (FAE) of co-culture of Caco-2 cells on permeable filters with Raji B-cells underneath from the viewpoint of particle transport. Exposure to tumor necrosis factor-α resulted in an almost maintained epithelial integrity/paracellular permeability combined with an increased nanoparticle transport in a dose-dependent manner while the effects of interleukin (IL)-1β were limited. Exposure to IL-6 significantly enhanced the nanoparticle transport with the limited disruption of the cell monolayer integrity.

View Article and Find Full Text PDF

[Improvement and prediction of intestinal drug absorption].

Yakugaku Zasshi

March 2014

Bioavailability Research Project, Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.

The suppository preparation, which can improve the absorption of poorly absorbable drugs safer than commercially available suppositories, was developed by utilizing sodium laurate and taurine. Additionally, the novel oral absorption-improving system was also established by utilizing polyamines and bile acids. Furthermore, to evaluate the efficacy of these new formulations and estimate the absorbability of new drug candidates in humans, the in vitro prediction system utilizing an isolated human intestinal tissues was developed and successfully predicted the fraction of dose absorbed for several model drugs.

View Article and Find Full Text PDF

Background: It is expected that oral cancer drug will provide ease of administration with decreased unwanted events to the patients. The purpose of this study is to prepare oral formulation of nano-oxaliplatin and examine the anticancer efficacy and safety. Nano-oxaliplatin was prepared utilizing our proprietary technology, the Fat Employing Supercritical Nano System (FESNS(®)).

View Article and Find Full Text PDF

Background: Oxaliplatin has long been used for the treatment of colorectal cancer via intra-venous infusion. In order to improve patient compliance, a solid dosage form for oral administration of oxaliplatin was prepared as nano-sized particles.

Method: Nano oxaliplatin was prepared employing Fat Employing Supercritical Nano System (FESNS(®)) with Supercritical Fluid (SCF) apparatus by using myristyl alcohol as solvent.

View Article and Find Full Text PDF

[Control of pulmonary absorption of drugs by various pharmaceutical excipients].

Yakugaku Zasshi

April 2007

Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima City, Japan.

In general, drugs are well absorbed from the lung, and the pulmonary absorption of therapeutic protein and peptide drugs, which are poorly absorbed from the gastrointestinal tract, was observed. However, locally acting drugs including antiasthmatic agents, bronchodilators, and expectorants should be localized for a long period in the lung tissues. In this study, the effects of various viscous vehicles on the absorption of theophylline and fluticasone propionate after intrapulmonary administration were examined in rats.

View Article and Find Full Text PDF

Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption.

J Control Release

October 2006

Bioavailability Research Project, Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd., 224-18 Ebino, Hiraishi, Kawauchi-cho, Tokushima 771-0182, Japan.

The synergetic improving effect of bile acids with spermine (SPM), a major polyamine, on the absorption of rebamipide, a poorly soluble and poorly absorbable drug (BCS Class IV), was evaluated in rats and beagle dogs. Although the absorption of rebamipide was improved by the addition of polyamines alone in normal rats, it was not improved in bile duct ligated (BDL) rats. The combinatorial use of sodium taurocholate (STC), a bile acid, with SPM improved the absorption of rebamipide even in BDL rats.

View Article and Find Full Text PDF

Optimization of suppository preparation containing sodium laurate and taurine that can safely improve rectal absorption of rebamipide.

Biol Pharm Bull

February 2006

Formulation Development 1, Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., 224-18 Ebino, Hiraishi, Kawauchi-cho, Tokushima 771-0182, Japan.

We previously reported that the fatty base suppository containing sodium laurate (C12) and taurine (Tau) (C12-Tau suppository) could enhance the colonic absorption of rebamipide, a poorly water-soluble and poorly absorbable drug, without any serious mucosal damages in rats. In the preset study, in order to make C12-Tau suppositories available for practical use, the scaling-up studies of animal and formulation size were performed, compared with the suppositories containing sodium caprate (C10) (C10 suppository) at the same amounts as those contained in the commercial products. Twenty-mg C12 improved the dissolution of rebamipide from suppository remarkably and the addition of 30-mg Tau only slightly decreased the dissolution rate.

View Article and Find Full Text PDF

In order to develop a novel oral formulation that can safely improve the intestinal absorption of poorly absorbable drugs, polyamines such as spermine (SPM) and spermidine (SPD) was examined as an absorption enhancing adjuvant in rats. The absorption of rebamipide, classified into BCS Class IV, from colon was significantly improved by SPM or SPD, and the enhancing ability of SPM was larger than that of SPD. As a possible mixing and/or interaction of polyamines with bile acids were expected, the combinatorial use of sodium taurocholate (STC) with polyamines was also examined.

View Article and Find Full Text PDF

Improvement in site-specific intestinal absorption of furosemide by Eudragit L100-55.

J Pharm Pharmacol

April 2001

Formulation Research Institute, Otsuka Pharmaceutical Factory, Inc, Naruto, Tokushima, Japan.

Furosemide (frusemide) is a weakly acidic diuretic drug. Its absorption is poor and variable, in part due to its restricted sites of absorption, mainly the stomach. The narrow absorption window of this drug can be explained by pH partition theory.

View Article and Find Full Text PDF

Small-Angle X-Ray Scattering Studies on Nucleation Formation of Dextran Precipitation in the Presence of Boron.

J Colloid Interface Sci

March 2000

Formulation Research Institute, Otsuka Pharmaceutical Factory, Inc., Kuguhara 115, Tateiwa, Muya-cho, Naruto, Tokushima, Japan

In the present study, the nucleation formation process of dextran precipitation in the presence of boron was investigated by small-angle X-ray scattering (SAXS) techniques. The formation mechanism of aggregates or nuclei is very important in the initial step of crystallization. SAXS measurement is an excellent technique for observing these processes.

View Article and Find Full Text PDF